Phenominer Database Results (41 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Record ID Study ID
OLETF abdominal fat pad weight control condition (for 16 hours) Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. abdominal fat pad mass male 210.0 days 5 60.8 g post excision weight measurement 0.0 67220 312
OLETF intramuscular fat area control condition Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50. intramuscular adipose amount male 245.0 days 7 3.26 mm2 0.2 0.52 ex vivo light microscopy with digital image analysis 0.0 67222 234
OLETF body weight control condition Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 body mass male 210.0 days 14 653.3 g 6.3 23.57 body weighing method 0.0 68068 836
OLETF blood glucose level temocapril (3.9 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood glucose amount male 364.0 days 11 182.88 mg/dl 7.38 24.48 blood glucose analysis 0.0 99419 2298
OLETF systolic blood pressure olmesartan medoxomil (3.8 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. arterial blood pressure trait male 364.0 days 12 undefined 132.1 mmHg 3.3 11.43 tail cuff plethysmography 0.0 99423 2298
OLETF blood total cholesterol level control condition (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood cholesterol amount male 364.0 days 12 168.73 mg/dl 8.88 30.76 blood cholesterol analysis 0.0 99431 2298
OLETF blood total cholesterol level temocapril (3.9 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood cholesterol amount male 364.0 days 11 78.38 mg/dl 2.7 8.96 blood cholesterol analysis 0.0 99434 2298
OLETF blood triglyceride level temocapril (3.9 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood triglyceride amount male 364.0 days 11 84.96 mg/dl 7.08 23.48 blood triglyceride analysis 0.0 99439 2298
OLETF plasma glucose level fasting (for 16 hours) then glucose solution Hirashima T, et al., Diabetes Res Clin Pract 1995 Feb;27(2):91-6. blood glucose amount male 210.0 days 14 289.0 mg/dl 8.55 32.0 oral glucose tolerance test 0.0 oral dose 120 min 67277 729
OLETF plasma glucose level fasting (for 16 hours) then glucose solution (2 g/kg) Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 blood glucose amount male 210.0 days 14 289.9 mg/dl 8.7 32.55 oral glucose tolerance test 0.0 oral glucose 120 min 68083 836
OLETF intramuscular fat area to body weight ratio control condition Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50. intramuscular adipose amount male 245.0 days 7 5.01 (mm2/g)/1000 0.87 2.29 ex vivo light microscopy with digital image analysis 0.0 67224 234
OLETF body weight control condition (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. body mass male 364.0 days 12 748.6 g 33.0 114.32 body weighing method 0.0 99411 2298
OLETF body weight temocapril (3.9 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. body mass male 364.0 days 11 766.7 g 13.9 46.1 body weighing method 0.0 99414 2298
OLETF blood glucose level control condition (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood glucose amount male 364.0 days 12 186.3 mg/dl 6.84 23.69 blood glucose analysis 0.0 99416 2298
OLETF diastolic blood pressure control condition (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. arterial blood pressure trait male 364.0 days 12 undefined 117.3 mmHg 4.9 16.97 tail cuff plethysmography 0.0 99426 2298
OLETF serum triglyceride level fasting (for 18 hours) Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. blood triglyceride amount male 246.0 days 23 218.77 mg/dl 13.47 64.62 serum triglyceride analysis carotid artery Triglyceride E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan 12359 248
OLETF plasma glucose level fasting (for 16 hours) then glucose solution Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. blood glucose amount male 210.0 days 14 149.2 mg/dl 3.0 11.22 oral glucose tolerance test glucose challenge min 12776 312
OLETF plasma glucose level fasting (for 16 hours) then glucose solution (2 g/kg) Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 blood glucose amount male 210.0 days 14 149.2 mg/dl 3.0 11.22 oral glucose tolerance test 0.0 oral glucose min 68071 836
OLETF plasma glucose level fasting (for 16 hours) then glucose solution (2 g/kg) Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 blood glucose amount male 210.0 days 14 352.8 mg/dl 8.6 32.18 oral glucose tolerance test 0.0 oral glucose 60 min 68077 836
OLETF body weight olmesartan medoxomil (3.8 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. body mass male 364.0 days 12 792.3 g 10.5 36.37 body weighing method 0.0 99413 2298
OLETF blood glucose level olmesartan medoxomil (0.35 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood glucose amount male 364.0 days 11 189.54 mg/dl 9.72 32.24 blood glucose analysis 0.0 99417 2298
OLETF systolic blood pressure temocapril (3.9 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. arterial blood pressure trait male 364.0 days 11 undefined 124.0 mmHg 3.2 10.61 tail cuff plethysmography 0.0 99424 2298
OLETF blood triglyceride level olmesartan medoxomil (0.35 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood triglyceride amount male 364.0 days 11 247.79 mg/dl 23.89 79.25 blood triglyceride analysis 0.0 99437 2298
OLETF body weight control condition Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50. body mass male 245.0 days 7 650.2 g 11.79 31.2 body weighing method 12201 234
OLETF serum total cholesterol level fasting (for 18 hours) Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. blood cholesterol amount male 246.0 days 23 90.1 mg/dl 2.2 10.56 serum total cholesterol measurement test carotid artery Cholesterol E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan 12352 248
OLETF body weight fasting (for 18 hours) Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. body mass male 246.0 days 23 641.0 g 6.92 33.21 body weighing method 12363 248
OLETF plasma glucose level fasting (for 16 hours) then glucose solution (for 0.5 hours) Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. blood glucose amount male 210.0 days 14 344.3 mg/dl 8.5 31.8 oral glucose tolerance test 0.0 glucose challenge 30 min 12777 312
OLETF body weight olmesartan medoxomil (0.35 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. body mass male 364.0 days 11 865.6 g 15.3 50.74 body weighing method 0.0 99412 2298
OLETF blood glucose level olmesartan medoxomil (3.8 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood glucose amount male 364.0 days 12 188.82 mg/dl 6.84 23.69 blood glucose analysis 0.0 99418 2298
OLETF systolic blood pressure olmesartan medoxomil (0.35 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. arterial blood pressure trait male 364.0 days 11 undefined 138.9 mmHg 5.0 16.58 tail cuff plethysmography 0.0 99422 2298
OLETF blood total cholesterol level olmesartan medoxomil (3.8 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood cholesterol amount male 364.0 days 12 93.44 mg/dl 5.02 17.39 blood cholesterol analysis 0.0 99433 2298
OLETF blood total cholesterol level olmesartan medoxomil (0.35 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood cholesterol amount male 364.0 days 11 153.28 mg/dl 7.72 25.61 blood cholesterol analysis 0.0 99432 2298
OLETF blood triglyceride level control condition (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood triglyceride amount male 364.0 days 12 232.74 mg/dl 32.74 113.43 blood triglyceride analysis 0.0 99436 2298
OLETF blood triglyceride level olmesartan medoxomil (3.8 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. blood triglyceride amount male 364.0 days 12 111.5 mg/dl 12.39 42.92 blood triglyceride analysis 0.0 99438 2298
OLETF serum leptin level fasting (for 18 hours) Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. blood leptin amount male 246.0 days 23 10.87 ng/ml 0.57 2.71 enzyme linked immunosorbent assay carotid artery 0 immunoreactive leptin kit; Morinaga Institute of Biological Science, Yokohama, Japan 65739 248
OLETF plasma glucose level fasting (for 16 hours) then glucose solution (2 g/kg) Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 blood glucose amount male 210.0 days 14 344.3 mg/dl 8.5 31.8 oral glucose tolerance test 0.0 oral glucose 30 min 68074 836
OLETF plasma glucose level fasting (for 16 hours) then glucose solution (2 g/kg) Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 blood glucose amount male 210.0 days 14 402.4 mg/dl 19.0 71.09 oral glucose tolerance test 0.0 oral glucose 90 min 68080 836
OLETF systolic blood pressure control condition (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. arterial blood pressure trait male 364.0 days 12 undefined 153.4 mmHg 4.3 14.9 tail cuff plethysmography 0.0 99421 2298
OLETF diastolic blood pressure olmesartan medoxomil (0.35 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. arterial blood pressure trait male 364.0 days 11 undefined 112.6 mmHg 4.7 15.59 tail cuff plethysmography 0.0 99427 2298
OLETF diastolic blood pressure temocapril (3.9 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. arterial blood pressure trait male 364.0 days 11 undefined 100.1 mmHg 3.3 10.94 tail cuff plethysmography 0.0 99429 2298
OLETF diastolic blood pressure olmesartan medoxomil (3.8 mg/kg/d) (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. arterial blood pressure trait male 364.0 days 12 undefined 100.8 mmHg 2.1 7.27 tail cuff plethysmography 0.0 99428 2298